Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat

Synapse

Volumn 23, Issue 3, 1996, Pages 125-131

  Clark, Robert N ^a   Ashby Jr , Charles R ^b   Dewey, Stephen L ^c   Ramachandran, P Veeraraghavan ^d   Strecker, Robert E ^a,e  

^a STONY BROOK UNIVERSITY   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

5HIAA; Antidepress ants; Cocaine; DOPAC; HVA; Microdialysis; Rat; Serotonin; SSRI; Striatum

Indexed keywords

DOPAMINE; FLUOXETINE;

ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT; SEROTONIN RELEASE;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CAUDATE NUCLEUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; EXTRACELLULAR SPACE; FLUOXETINE; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0029946551     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199607)23:3<125::AID-SYN1>3.0.CO;2-A     Document Type: Article

References (22)

1. Baldessarini, R.J., Marsh, E.R., and Kula, N.S. (1992) Interactions of fluoxetine with metabolisim of dopamine and serotonin in rat brain regions. Brain Res., 579:152-156.
2. Björklund, A., and Lindvall, O. (1986) Catecholaminergic brain stem regulatory systems. In: Handbook of Physiology: The Nervous System Vol. 4, Intrinsic Regulatory Systems in the Brain. F.E. Bloom, Ed. American Physiological Society, Bethesda, MD, pp. 155-235.
3. Blandina, P., Goldfarb, J., Craddock-Royal, B., and Green, J.P. (1989) Release of endogenous dopamine by stimulation of 5-hydroxytryptamine 3 receptors in rat striatum. J. Pharmacol. Exp. Ther., 251:803-809.
4. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res., 543:354-357.
5. Dewey, S.L., Smith, G.S., Logan, J.S., Alexoff, D., Ding, Y.S., King, P.T., Pappas, N., Brodie, J.D., and Ashby, C.R. (1995) Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J. Neurosci., 15:821-829.
6. Guan, X.-M., and McBride, W.J. (1988) Serotonin microfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull., 23:541-547.
7. Herve, R.M., Pickel, V.M., Joh, T.H., and Beaudet, A. (1987) Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons. Brain Res., 435:71-83.
8. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronocoulometric study. Brain Res., 513:156-160.
9. Kapur, S., and Mann, J.J. (1992) Role of the dopaminergic system in depression. Biol. Psychiatry, 32:1-17.
10. 3 receptors in rat brain using radioligand binding. Nature, 330:746-748.
11. Lipinski, J.F., Mallya, G., Zimmerman, P., and Pope, H.G. (1989) Fluoxetine-induced akathisia: Clinical and theoretical implications. J. Clin. Psychiatry, 50:339-342.
12. Meltzer, H.Y., Young, M., Metz, J., Fang, V.S., Schyve, P.M., and Arora, R.C. (1979) Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J. Neural Trans. 45:165-175.
13. Parsons, L.H., and Justice, J.B. Jr. (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res., 606:195-199.
14. Perry, K.W., and Fuller, R.W. (1992) Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striaturn. Life Sci., 50:1683-1690.
15. Robinson, T.E., and Camp, D.M. (1991) The feasibility of repeated microdialysis for within-subjects design experiments: studies on the mesostriatal dopamine system. In: Microdialysis in the Neurosciences. T.E. Robinson and J.B. Justice, eds. Amsterdam, Elsevier, pp. 189-234.
16. Rutter, J.J., and Auerbach, S.B. (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther., 265:1319-1324.
17. Schott, A., Maloteaux, J.M., and Laduron, P.M. (1984) Solubilization of serotonin S2-receptors from human brain. Eur. J. Pharmacol., 100:329-333.
18. Srebnik, M., Ramachandran, P.V., and Brown, H.C. (1988) Chiral synthesis via organoboranes. 18. Selective Reductions. 43. Diisopinocampheylchloroborane as an excellent chiral reducing reagent for the synthesis of halo alcohols of high enantiomeric purity. A high enantioselective synthesis of both optical isomers of tomoxetine, fluoxetine, and nisoxetine. J. Org. Chem., 53:2916-2920.
19. Tanda, G., Carboni, E., Frau, R., and Di Chiara, G. (1994) Increase of extracellular dopamine in the prefrontal cortex: A trait of drugs with antidepressant potential? Psychopharmacology, 115:285-288.
20. Tanda, G., Frau, R., and Di Chiara, G. (1995) Local 5HT3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex. Psychopharmacology, 119:15-19.
21. Van der Kooy, D., and Hattori, T. (1980) Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: A fluorescent retrograde double labeling study in the rat. Brain Res., 186:1-7.
22. Wong, D.T., Bymaster, F.P., and Engleman, E.A. (1995) Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci., 57:411-441.